Sheĭtanov I
Vutr Boles. 1990;29(4):59-64.
In 25 patients with rheumatoid arthritis the action of D-penicilamine (Cuprenyl) on the following indices was studied: IgG, IgA, IgM, circulating immune complexes (CIC), rheumatoid factor titer (RF), T- and B-lymphocytes in the peripheral blood. The action on some clinico-laboratory indices was also studied--joint index, duration of morning stiffness, erythrocytes sedimentation rate. The results reveal that the D-penicilamine treatment leads to a lowering of the immunoglobulins, circulating immune complexes and rheumatoid factor titer which is most expressed between the 3 and 6 month from the beginning of the treatment. This drug does not influence significantly the percentage of T- and B-lymphocytes in the peripheral blood.
对25例类风湿性关节炎患者,研究了D-青霉胺( Cuprenyl)对以下指标的作用:IgG、IgA、IgM、循环免疫复合物(CIC)、类风湿因子滴度(RF)以及外周血中的T淋巴细胞和B淋巴细胞。还研究了其对一些临床实验室指标的作用——关节指数、晨僵持续时间、红细胞沉降率。结果显示,D-青霉胺治疗可使免疫球蛋白、循环免疫复合物和类风湿因子滴度降低,在治疗开始后的3至6个月最为明显。该药物对外周血中T淋巴细胞和B淋巴细胞的百分比没有显著影响。